A pair of highly complex intestinal transplants, each a first of its kind, demonstrate the willingness to push boundaries to achieve the best outcome for patients.
Read MoreThe Future of CAR T-Cell Therapy
Dr. J. Joseph Melenhorst and his team are researching ways to build on what is possible with CAR T-cell therapy.
Lung Transplantation in Rheumatic Lung Disease: The Importance of a Multidisciplinary Approach
When considering a lung transplant for a patient with rheumatic lung disease, the multi-system nature of the disease can significantly increase complexity.
Program Enhances Chart Access for Hospital Inpatients
Patients on some Cleveland Clinic units can use their own mobile devices to gain access to robust information about their medications, hospital care team members and managing their health conditions.
Diagnosis and Management of Postural Orthostatic Tachycardia Syndrome (Podcast)
Long COVID is raising the number and prominence of POTS cases, but long-standing diagnostic challenges and misconceptions around this autoimmune condition persist.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Closed-Loop Technology Significantly Helps Some Back Pain Sufferers
Since 2017, Cleveland Clinic has been among a handful of healthcare systems participating in trials for an implanted neurostimulator that self-adjusts in real time. Studies have shown relief and durability are better than with open-loop systems.
Staff Education Improves Fidelity of Dementia Screening and Early Intervention
Ongoing clinical training improves the ability of caregivers to interpret screening tests and diagnose dementia in geriatric patients.
Anti-Tumor Necrosis Factor Reduces Crohn’s Disease Recurrence after Surgery
Patients with Crohn’s disease who were administered anti-tumor necrosis factor within a month after undergoing ileocecal resection were less likely to experience disease recurrence, new Cleveland Clinic research shows.
Coronary Sinus Reducing Device: A New Option for Refractory Angina May Soon Be at Hand
The recently launched COSIRA-II trial is assessing the NeoVasc Reducer device for treating severe refractory angina in patients ineligible for revascularization.
Taking Aim at Diabetes: A Structured Education and Management Program
Multidisciplinary diabetes management program targets the unique needs of rural patients through education and regular monitoring.